MEDXT Surges 3.608% Amid Bitforex Delisting, Tech Advances

MEDXT's latest price was $0.002646, up 3.608% in the last 24 hours. The MEDXT project has recently addressed a suspension incident on Bitforex exchange. In late July 2025, Bitforex unexpectedly halted trading and withdrawals for MEDXT, later announcing the token's delisting. The MEDXT team clarified that this was solely Bitforex's decision, unrelated to any compromise of the MEDXT token itself or its underlying blockchain technology. They assured holders that the MEDXT blockchain remained secure and fully functional throughout the event. The team actively assisted users in transferring their assets to alternative Solana-based platforms for continued trading and liquidity access following the delisting. This proactive response aimed to minimize disruption for the MEDXT community.

Significant progress has been made on MEDXT's technological infrastructure. The project completed a crucial migration of its blockchain platform to Solana, finalized in the first quarter of 2025. This transition leverages Solana's high throughput and scalability to enhance the performance and capability of MEDXT's core systems. Development of the dedicated MEDXT Marketplace application is ongoing and nearing completion. This application is central to MEDXT's utility, designed to facilitate secure, decentralized transactions involving anonymized medical data sets, aligning with the project's mission to empower patient control over health data.

MEDXT continues to navigate the evolving regulatory landscape. The project acknowledges an ongoing lawsuit filed by the U.S. Securities and Exchange Commission (SEC) against MEDXT Labs. This legal challenge, which the MEDXT team is contesting, centers on regulatory classifications within the digital asset space. Updates regarding the case's progress are anticipated within the year as court proceedings continue. Meanwhile, MEDXT Labs continues its operational development activities independent of the litigation. Preparations for the release of a comprehensive new whitepaper are underway. This document is expected to provide detailed technical and operational updates on the MEDXT ecosystem, including the finalized marketplace application and future development roadmap.